Visualization of hypoxia in microscopic tumors by immunofluorescent microscopy

被引:98
作者
Li, Xiao-Feng [1 ]
Carlin, Sean [1 ]
Urano, Muneyasu [1 ]
Russell, James [1 ]
Ling, C. Clifton [1 ]
O'Donoghue, Joseph A. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA
关键词
D O I
10.1158/0008-5472.CAN-06-4353
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumor hypoxia is commonly observed in primary solid malignancies but the hypoxic status of subclinical micro-metastatic disease is largely unknown. The distribution of hypoxia in microscopic tumors was studied in animal models of disseminated peritoneal disease and intradermal (i.d.) growing tumors. Tumors derived from human colorectal adenocarcinoma cell lines HT29 and HCT-8 ranged in size from a few hundred microns to several millimeters in diameter. Hypoxia was detected by immunofluorescent visualization of pimonidazole and the hypoxia-regulated protein carbonic anhydrase 9. Tumor blood perfusion, cellular proliferation, and vascularity were visualized using Hoechst 33342, bromodeoxyuridine, and CD31 staining, respectively. In general, tumors of <1 mm diameter were intensely hypoxic, poorly perfused, and possessed little to no vasculature. Larger tumors (similar to 1-4 mm diameter) were well perfused with widespread vasculature and were not significantly hypoxic. Patterns of hypoxia in disseminated peritoneal tumors and i.d. tumors were similar. Levels of hypoxia in microscopic peritoneal tumors were reduced by carbogen breathing. Peritoneal and i.d. tumor models are suitable for studying hypoxia in microscopic tumors. If the patterns of tumor hypoxia in human patients are similar to those observed in these animal experiments, then the efficacy of systemic treatments of micrometastatic disease may be compromised by hypoxic resistance.
引用
收藏
页码:7646 / 7653
页数:8
相关论文
共 41 条
[11]   Regulation of angiogenesis by hypoxia-inducible factor 1 [J].
Hirota, Kiichi ;
Semenza, Gregg L. .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2006, 59 (01) :15-26
[12]   GLUTI and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON [J].
Hoskin, PJ ;
Sibtain, A ;
Daley, FM ;
Wilson, GD .
BRITISH JOURNAL OF CANCER, 2003, 89 (07) :1290-1297
[13]   Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy [J].
Jain, RK .
SCIENCE, 2005, 307 (5706) :58-62
[14]   Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O-2 tension [J].
Jiang, BH ;
Semenza, GL ;
Bauer, C ;
Marti, HH .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1996, 271 (04) :C1172-C1180
[15]  
Kaanders JHAM, 2002, CANCER RES, V62, P7066
[16]   ARCON: a novel biology-based approach in radiotherapy [J].
Kaanders, JHAM ;
Bussink, J ;
van der Kogel, AJ .
LANCET ONCOLOGY, 2002, 3 (12) :728-737
[17]   Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for laryngeal cancer [J].
Kaanders, JHAM ;
Pop, LAM ;
Marres, HAM ;
Liefers, J ;
van den Hoogen, FJA ;
van Daal, WAJ ;
van der Kogel, AJ .
RADIOTHERAPY AND ONCOLOGY, 1998, 48 (02) :115-122
[18]  
Koukourakis MI, 2001, CLIN CANCER RES, V7, P3399
[19]  
Le QT, 2003, CLIN CANCER RES, V9, P59
[20]   The effect of tumor size on necrosis and polarographically measured pO(2) [J].
Milross, CG ;
Tucker, SL ;
Mason, KA ;
Hunter, NR ;
Milas, L .
ACTA ONCOLOGICA, 1997, 36 (02) :183-189